Vancomycin Dosing in Neutropenic Patients

Open Access

Peer-reviewed

Research Article

Michiel B. Haeseker ,

* E-mail: m.haeseker@mumc.nl

Affiliations Department of Medical Microbiology, Maastricht University Medical Center, Maastricht, the Netherlands, Care and Public Health Research Institute (CAPHRI), Maastricht, the Netherlands
⨯
Sander Croes,

Affiliation Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, the Netherlands
⨯
Cees Neef,

Affiliation Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, the Netherlands
⨯
Cathrien A. Bruggeman,

Affiliations Department of Medical Microbiology, Maastricht University Medical Center, Maastricht, the Netherlands, Care and Public Health Research Institute (CAPHRI), Maastricht, the Netherlands
⨯
Leo M. L. Stolk,

Affiliation Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, the Netherlands
⨯
Annelies Verbon

Affiliations Department of Medical Microbiology, Maastricht University Medical Center, Maastricht, the Netherlands, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
⨯

Reader Comments (0)

Vancomycin
Is the Subject Area "Vancomycin" applicable to this article?

Thanks for your feedback.
Neutropenia
Is the Subject Area "Neutropenia" applicable to this article?

Thanks for your feedback.
Creatinine
Is the Subject Area "Creatinine" applicable to this article?

Thanks for your feedback.
Sepsis
Is the Subject Area "Sepsis" applicable to this article?

Thanks for your feedback.
Hematologic cancers and related disorders
Is the Subject Area "Hematologic cancers and related disorders" applicable to this article?

Thanks for your feedback.
Pharmacokinetics
Is the Subject Area "Pharmacokinetics" applicable to this article?

Thanks for your feedback.
Hematology
Is the Subject Area "Hematology" applicable to this article?

Thanks for your feedback.
Antibiotics
Is the Subject Area "Antibiotics" applicable to this article?

Thanks for your feedback.